STERISHEALTHCARE Products
Mumbai info@sterispharma.com
918824175417
Chat with us  

Chat with us on WhatsApp

×
Preview

This is your website preview.

Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360 android app / iOS App / web portal.

STERISHEALTHCARE 573431969ec6680ff811d9bc Products https://www.sterisindia.com
Home pancreatic beta cells

Items tagged with 'pancreatic beta cells'

{ "products": [ { "_id": "68d51d9a26579f4bc195771a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Glimepiride IP1 mg, Voglibose IP 0.2 MG & Metformin Hydrochloride IP 500 mg ", "description": "GLIMITERIS MV1 0.2 is an advanced fixed-dose combination (FDC) medication designed for adults with Type 2 Diabetes Mellitus (T2DM) who require more than lifestyle modifications or single/dual therapy to maintain optimal blood sugar levels. This innovative formulation brings together the power of three well-established antidiabetic agents—Glimepiride (1 mg), Voglibose (0.2 mg), and Metformin Hydrochloride SR (500 mg)—to provide comprehensive glycemic control.\n\nIt is particularly effective for patients struggling with postprandial hyperglycemia, fasting glucose regulation, and HbA1c reduction, making it a preferred choice in cases of poorly controlled diabetes.\n\n \n\nMechanism of Action\nThe therapeutic benefit of GLIMITERIS MV1 0.2 comes from the unique synergy of its three components, each targeting different aspects of glucose metabolism:\n\n1. Glimepiride (1 mg) – Sulfonylurea\nStimulates insulin secretion by activating pancreatic beta cells.\n\nProvides a long-lasting effect with comparatively lower hypoglycemia risk than older sulfonylureas.\n\nHelps reduce both fasting and postprandial glucose levels.\n\n2. Voglibose (0.2 mg) – Alpha-Glucosidase Inhibitor\nDelays the breakdown and absorption of carbohydrates in the intestine.\n\nMinimizes post-meal glucose spikes (PPBG).\n\nActs locally in the gut and has minimal systemic absorption, which reduces systemic side effects.\n\n3. Metformin Hydrochloride SR (500 mg) – Biguanide\nDecreases hepatic glucose production (gluconeogenesis).\n\nImproves peripheral insulin sensitivity, enhancing glucose uptake in muscles.\n\nDoes not cause hypoglycemia on its own.\n\nThe sustained-release (SR) formulation ensures extended control and reduces gastrointestinal side effects.\n\n \n\nIndications\nGLIMITERIS MV1 0.2 is indicated for:\n\nAdults with Type 2 Diabetes Mellitus.\n\nPatients inadequately controlled with monotherapy or dual therapy.\n\nManagement of fasting and postprandial hyperglycemia.\n\nLong-term HbA1c reduction as part of a comprehensive diabetes care plan.\n\n \n\nKey Benefits\n✅ Comprehensive Blood Sugar Control – Acts on fasting, post-meal, and long-term HbA1c levels.\n✅ Postprandial Spike Management – Voglibose effectively controls carbohydrate-induced sugar surges.\n✅ Reduced Pill Burden – Combines three medicines into a single tablet.\n✅ Lower Hypoglycemia Risk – Metformin and Voglibose balance out Glimepiride’s insulin-secreting effect.\n✅ Weight Management Support – Metformin may promote modest weight loss or prevent weight gain.\n✅ Improved Tolerability – SR formulation of Metformin enhances gastrointestinal comfort.\n\n \n\nDosage and Administration\nRecommended dose: One tablet once or twice daily with meals, or as directed by the physician.\n\nAdministration tips:\n\nTake with the first bite of a main meal to maximize Voglibose’s effect.\n\nSwallow whole with water; do not crush or chew the SR tablet.\n\nDose adjustments: Based on blood sugar monitoring, clinical response, and renal/hepatic function.\n\n \n\nContraindications\nGLIMITERIS MV1 0.2 is not suitable for patients with:\n\nType 1 diabetes or diabetic ketoacidosis.\n\nSevere renal impairment (eGFR <30 mL/min/1.73 m²).\n\nHepatic dysfunction.\n\nSevere gastrointestinal diseases.\n\nHistory of lactic acidosis.\n\nHypersensitivity to Glimepiride, Voglibose, or Metformin.\n\nPregnancy and lactation (unless strictly advised by a physician).\n\n \n\nWarnings and Precautions\nHypoglycemia: Risk is higher when combined with other antidiabetics or with missed meals.\n\nLactic Acidosis: A rare but life-threatening effect of Metformin—renal function monitoring is essential.\n\nGI Side Effects: Voglibose and Metformin may cause bloating, flatulence, or diarrhea (usually temporary).\n\nVitamin B12 Monitoring: Long-term Metformin use may reduce B12 absorption.\n\nLiver and Kidney Function: Regular monitoring is recommended for safe long-term use.\n\n \n\nAdverse Effects\nCommon:\nGlimepiride: Mild hypoglycemia, dizziness, slight weight gain.\n\nVoglibose: Gas, abdominal discomfort, mild diarrhea.\n\nMetformin SR: Nausea, bloating, metallic taste, loose stools.\n\nRare but Serious:\nLactic acidosis (from Metformin).\n\nSevere hypoglycemia (especially if meals are skipped).\n\nAllergic reactions such as rash, itching, or swelling.\n\nElevated liver enzymes.\n\nSeek medical attention if symptoms such as rapid breathing, confusion, severe fatigue, or muscle pain occur.\n\n \n\nDrug Interactions\nIncreased hypoglycemia risk: With insulin, beta-blockers, and sulfonylureas.\n\nReduced Metformin efficacy: With corticosteroids, estrogens, and diuretics.\n\nLactic acidosis risk: Higher with alcohol or iodinated contrast agents. ", "price": 263.0, "discountamount": 80.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2182, "imageuri": "https://productimages.withfloats.com/actual/68d51d9cdf1a4ca2c252370a.png", "tileimageuri": "https://productimages.withfloats.com/tile/68d51d9cdf1a4ca2c252370a.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-25T10:46:50.098Z", "updatedon": "2025-09-25T10:46:50.098Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glimepiride-ip1-mg-voglibose-ip-0-2-mg-metformin-hydrochloride-ip-500-mg-/2182", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIMITERIS MV1 0.2", "category": "", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68134d097702eb2332e5ccb0", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLICLAGLAZE 40", "description": "GLICLAGLAZE 40 is an oral antidiabetic medication containing Gliclazide 40 mg, formulated to effectively manage Type 2 Diabetes Mellitus. It belongs to the class of drugs known as sulfonylureas, which are specifically designed to control blood glucose levels in adults who cannot manage diabetes through diet and exercise alone. By promoting insulin secretion and improving glycemic control, GLICLAGLAZE 40 helps prevent long-term complications associated with uncontrolled diabetes, such as nerve damage, kidney issues, and cardiovascular diseases.\n\nKey Ingredient\nGliclazide (40 mg):\nGliclazide is a second-generation sulfonylurea, known for its dual effect: stimulating insulin release from the pancreas and offering antioxidant properties. It not only lowers blood sugar but also provides vascular protection, making it suitable for patients at risk of cardiovascular events.\n\nKey Benefits\nEffectively reduces high blood sugar levels in Type 2 diabetes\n\nStimulates natural insulin secretion from pancreatic beta cells\n\nProvides cardiovascular protection by improving endothelial function\n\nMinimizes the risk of microvascular complications like retinopathy and nephropathy\n\nSuitable for long-term glycemic control when lifestyle measures are insufficient\n\nHelps maintain a stable glucose profile throughout the day\n\nHow Does It Work?\nGLICLAGLAZE 40 works by targeting the pancreas to enhance the secretion of insulin, which is essential for lowering blood glucose levels. Gliclazide binds to specific receptors on pancreatic beta cells, triggering the release of insulin in a glucose-dependent manner. This ensures that the medication works primarily when glucose levels are elevated, thus reducing the risk of hypoglycemia compared to older sulfonylureas. Additionally, its antioxidant properties contribute to improved vascular health, protecting blood vessels from oxidative damage often seen in diabetic patients.\n\nDirections for Use\nTake GLICLAGLAZE 40 exactly as prescribed by your healthcare provider\n\nUsually taken once or twice daily, preferably before meals\n\nSwallow the tablet whole with water — do not crush or chew\n\nMaintain a regular schedule for meals and medication to avoid hypoglycemia\n\nMonitor blood glucose levels regularly to track progress\n\nAlways combine with a balanced diet and exercise plan for optimal results\n\nSide Effects\nThough generally well-tolerated, GLICLAGLAZE 40 may cause some side effects:\n\nCommon Side Effects:\n\nHypoglycemia (low blood sugar)\n\nHeadache\n\nDizziness or light-headedness\n\nNausea or stomach discomfort\n\nWeight gain (in some patients)\n\nRare but Serious Side Effects:\n\nLiver enzyme abnormalities\n\nSkin rash or allergic reaction\n\nBlood disorders like anemia or thrombocytopenia\n\nVisual disturbances (usually temporary)\n\nSeek immediate medical attention if symptoms of severe hypoglycemia, such as confusion, fainting, or seizures, occur.", "price": 120.0, "discountamount": 34.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "gliclaglaze 40", "exercise plan", "balanced diet", "meals swallow", "nephropathy suitable", "gliclaglaze 40gliclaglaze 40", "seizures occur", "confusion fainting", "severe hypoglycemia", "medical attention", "temporary seek", "patients rare", "lightheadedness nausea", "track progress", "regular schedule", "daily preferably", "healthcare provider", "oxidative damage", "hypoglycemia compared", "glucosedependent manner", "specific receptors", "lifestyle measures", "microvascular complications", "secondgeneration sulfonylurea", "uncontrolled diabetes", "manage diabetes", "specifically designed", "chew maintain", "glucose levels", "cardiovascular protection", "promoting insulin secretion", "diabetic patients directions", "older sulfonylureas additionally", "medication works primarily", "oral antidiabetic medication", "stable glucose profile", "insufficient helps maintain", "vascular protection making", "thrombocytopenia visual disturbances", "antioxidant properties contribute", "longterm glycemic control", "pancreatic beta cells", "lowers blood sugar", "offering antioxidant properties" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2099, "imageuri": "https://productimages.withfloats.com/actual/68134d0b4b698d44a8c316f4.png", "tileimageuri": "https://productimages.withfloats.com/tile/68134d0b4b698d44a8c316f4.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-05-01T10:29:29.141Z", "updatedon": "2025-05-01T10:29:29.141Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/gliclaglaze-40/2099", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Gliclazide 40 mg", "category": "DIABETIC RANGE", "tags": [ "Gliclazide 40 mg uses in Hindi", "Gliclazide 40mg brands", "Gliclazide 40 mg price", "Gliclazide 40mg side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "668e8611b9f7300708fe1240", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TRIOGLIMITERIS 1/0.2 ", "description": "TRIOGLIMITERIS 1/0.2 \nVoglibose 0.2 mg, Glimepiride 1 mg & Metformin Hydrochloride 500 mg\nIntroduction\n\nTRIOGLIMITERIS 1/0.2 is a combination medication containing Voglibose, Glimepiride, and Metformin Hydrochloride. It is primarily used in the management of type 2 diabetes mellitus to improve glycemic control through different mechanisms of action targeting glucose metabolism.\n\nComposition\n\nVoglibose (0.2 mg): An alpha-glucosidase inhibitor that delays the digestion of carbohydrates in the intestine, thereby reducing postprandial blood glucose levels.\nGlimepiride (1 mg): A sulfonylurea derivative that stimulates insulin release from pancreatic beta cells, enhancing glucose uptake in peripheral tissues.\nMetformin Hydrochloride (500 mg): A biguanide that decreases hepatic glucose production, improves insulin sensitivity in peripheral tissues, and reduces intestinal glucose absorption.\nMechanism of Action\n\nTRIOGLIMITERIS 1/0.2 combines the actions of its components to achieve optimal glycemic control:\n\nVoglibose: Inhibits alpha-glucosidase enzymes in the intestine, delaying carbohydrate digestion and reducing the absorption of glucose after meals.\nGlimepiride: Stimulates insulin secretion from pancreatic beta cells in a glucose-dependent manner, thereby lowering blood glucose levels.\nMetformin Hydrochloride: Decreases hepatic glucose production through suppression of gluconeogenesis and enhances peripheral glucose uptake and utilization by improving insulin sensitivity.\nIndications\n\nTRIOGLIMITERIS 1/0.2 is indicated for:\n\nType 2 Diabetes Mellitus: Used to improve glycemic control in adults when diet, exercise, and monotherapy with metformin or sulfonylureas alone are not sufficient.\nDosage and Administration\n\nThe typical dosage of TRIOGLIMITERIS 1/0.2 is one tablet taken orally with meals, usually once or twice daily.\nDosage adjustments may be required based on individual patient response, blood glucose levels, and renal function.\nIt is essential to adhere to the prescribed dosage regimen to achieve optimal therapeutic outcomes.\nSide Effects\n\nCommon side effects of TRIOGLIMITERIS 1/0.2 may include:\n\nHypoglycemia (especially when used in combination with insulin or other antidiabetic medications)\nGastrointestinal disturbances (such as nausea, vomiting, diarrhea, or abdominal discomfort)\nWeight gain (mainly associated with sulfonylureas)\nMore severe side effects can include:\n\nAllergic reactions (rash, itching, swelling)\nLactic acidosis (rare but serious adverse effect associated with metformin use)\nHepatic dysfunction (monitor liver function tests periodically)\nPrecautions\n\nUse with caution in patients with renal impairment, hepatic dysfunction, or other significant medical conditions that may affect drug metabolism or excretion.\nRegular monitoring of blood glucose levels, renal function, and liver function is recommended during treatment with TRIOGLIMITERIS 1/0.2.\nAvoid use in patients with type 1 diabetes mellitus or diabetic ketoacidosis.\nDrug Interactions\n\nTRIOGLIMITERIS 1/0.2 may interact with other medications affecting blood glucose levels, such as insulin, other oral antidiabetic agents, or drugs that affect renal function or hepatic metabolism. Close monitoring and dose adjustments may be necessary.\nConclusion\n\nTRIOGLIMITERIS 1/0.2 provides a comprehensive approach to managing type 2 diabetes mellitus by combining Voglibose, Glimepiride, and Metformin Hydrochloride. This combination targets different aspects of glucose metabolism, enhancing insulin secretion, reducing hepatic glucose production, and delaying carbohydrate absorption in the intestine. Proper dosage, administration, and monitoring for side effects are essential to achieve and maintain optimal glycemic control in diabetic patients using TRIOGLIMITERIS 1/0.2. Consultation with a healthcare provider is recommended for personalized treatment plans and management of diabetes with this medication.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n", "price": 195.0, "discountamount": 58.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "500 mg", "0.2 mg", "one tablet", "Weight gain", "Glimepiride 1", "metformin use", "Proper dosage", "Glimepiride (1", "dosage regimen", "typical dosage", "renal function", "insulin release", "drug metabolism", "Lactic acidosis", "Close monitoring", "dose adjustments", "renal impairment", "diabetic patients", "insulin secretion", "different aspects", "Drug Interactions", "other medications", "Regular monitoring", "Dosage adjustments", "Allergic reactions", "peripheral tissues", "hepatic metabolism", "glucose metabolism", "insulin sensitivity", "healthcare provider", "Hepatic dysfunction", "Common side effects", "abdominal discomfort", "different mechanisms", "liver function tests", "diabetic ketoacidosis", "pancreatic beta cells", "combination medication", "carbohydrate digestion", "comprehensive approach", "serious adverse effect", "Metformin Hydrochloride", "carbohydrate absorption", "sulfonylurea derivative", "glucose-dependent manner", "optimal glycemic control", "type 1 diabetes mellitus", "type 2 diabetes mellitus", "More severe side effects", "alpha-glucosidase enzymes", "peripheral glucose uptake", "hepatic glucose production", "alpha-glucosidase inhibitor", "individual patient response", "personalized treatment plans", "optimal therapeutic outcomes", "Gastrointestinal disturbances", "intestinal glucose absorption", "other antidiabetic medications", "other oral antidiabetic agents", "postprandial blood glucose levels", "other significant medical conditions" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1939, "imageuri": "https://productimages.withfloats.com/actual/668e86143a68154e11e7d822.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/668e86143a68154e11e7d822.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-10T13:01:05.875Z", "updatedon": "2024-07-10T13:01:05.875Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/trioglimiteris-1-0-2-/1939", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TRIOGLIMITERIS 1/0.2 ", "category": "DIABETIC RANGE", "tags": [ "glimepiride 1mg+metformin 500mg+voglibose 0.2 mg", "Glimepiride 2mg Metformin 500mg Voglibose 0.2 mg b", "glimepiride 2mg+metformin 500mg+voglibose 0.2 mg", "voglibose glimepiride & metformin hydrochloride (s", "voglibose glimepiride + metformin hydrochloride us", "glimepiride 1mg+metformin 500mg+voglibose 0.3 mg", "glimepiride 2mg+metformin 500mg+voglibose 0.2 mg g", "" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "668d24ff75f1701d34699e32", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLICLAGLAZE 80 ", "description": "GLICLAGLAZE 80 \nGliclazide (80mg)\nOverview\nGLICLAGLAZE 80 is an oral medication containing Gliclazide at a dosage of 80 mg. Gliclazide belongs to the class of drugs known as sulfonylureas and is primarily used to manage type 2 diabetes mellitus. It helps control blood sugar levels by stimulating the release of insulin from the pancreatic beta cells. GLICLAGLAZE 80 is an effective treatment option for individuals who require oral hypoglycemic therapy to maintain optimal blood glucose levels.\n\nBenefits of Gliclazide\n\nBlood Sugar Control\n\nGliclazide effectively lowers blood glucose levels by increasing insulin secretion.\nHelps prevent complications associated with diabetes, such as neuropathy, nephropathy, and retinopathy.\nReduced Risk of Hypoglycemia\n\nCompared to some other sulfonylureas, Gliclazide has a lower risk of causing hypoglycemia (low blood sugar levels).\nIt provides a balanced approach to managing blood sugar without causing excessive drops in glucose levels.\nCardiovascular Benefits\n\nStudies suggest that Gliclazide may have a protective effect on the cardiovascular system.\nIt may reduce the risk of cardiovascular events in diabetic patients, promoting overall heart health.\nImproved Glycemic Control\n\nHelps achieve and maintain target HbA1c levels, reflecting long-term glycemic control.\nCan be used in combination with other oral antidiabetic agents or insulin to enhance its effectiveness.\nUsage and Dosage\nGLICLAGLAZE 80 should be taken as prescribed by a healthcare professional. The typical starting dose is 40 to 80 mg daily, which can be adjusted based on the patient's blood glucose response. It is usually taken with meals to maximize its effectiveness and minimize gastrointestinal side effects. Consistent use and adherence to prescribed dosage are crucial for optimal results.\n\nIndications for Use\n\nType 2 Diabetes Mellitus: GLICLAGLAZE 80 is indicated for the management of type 2 diabetes in patients who cannot achieve adequate glycemic control through diet and exercise alone.\nCombination Therapy: It can be used in conjunction with other oral hypoglycemic agents or insulin to achieve better blood sugar control.\nSide Effects\nGLICLAGLAZE 80 is generally well-tolerated. However, some patients may experience side effects, including:\n\nHypoglycemia: Although less common, low blood sugar can occur, especially if meals are skipped or combined with excessive physical activity.\nGastrointestinal Issues: Nausea, abdominal pain, and diarrhea may occur but are usually mild and transient.\nAllergic Reactions: Rarely, allergic reactions such as skin rash, itching, or hives may occur.\nPrecautions and Contraindications\n\nLiver and Kidney Impairment: Patients with severe liver or kidney disease should use GLICLAGLAZE 80 with caution, as it may require dose adjustments.\nPregnancy and Lactation: Gliclazide is not recommended during pregnancy or breastfeeding. Alternative treatments should be considered.\nDrug Interactions: Inform your healthcare provider about all medications and supplements you are taking, as Gliclazide can interact with other drugs, potentially altering its effectiveness.\nConclusion\nGLICLAGLAZE 80 is a reliable and effective oral medication for managing type 2 diabetes mellitus. By stimulating insulin secretion, it helps control blood sugar levels, reducing the risk of diabetes-related complications. Its balanced approach to glycemic control, combined with potential cardiovascular benefits, makes GLICLAGLAZE 80 a valuable addition to diabetes management plans. Under the guidance of a healthcare professional, GLICLAGLAZE 80 can significantly improve the quality of life for individuals with type 2 diabetes, promoting better long-term health outcomes.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n", "price": 265.0, "discountamount": 79.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "skin rash", "lower risk", "40 to 80 mg", "other drugs", "severe liver", "Reduced Risk", "Consistent use", "kidney disease", "abdominal pain", "excessive drops", "optimal results", "dose adjustments", "diabetic patients", "insulin secretion", "valuable addition", "Drug Interactions", "Kidney Impairment", "protective effect", "balanced approach", "Allergic Reactions", "healthcare provider", "Combination Therapy", "other sulfonylureas", "Blood Sugar Control", "target HbA1c levels", "overall heart health", "cardiovascular events", "cardiovascular system", "typical starting dose", "pancreatic beta cells", "Alternative treatments", "blood glucose response", "low blood sugar levels", "healthcare professional", "Gastrointestinal Issues", "type 2 diabetes mellitus", "diabetes management plans", "adequate glycemic control", "effective oral medication", "long-term health outcomes", "oral hypoglycemic therapy", "long-term glycemic control", "effective treatment option", "excessive physical activity", "optimal blood glucose levels", "gastrointestinal side effects", "diabetes-related complications", "other oral hypoglycemic agents", "other oral antidiabetic agents", "potential cardiovascular benefits" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1922, "imageuri": "https://productimages.withfloats.com/actual/668d2505c34ba6457aa3fb4d.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/668d2505c34ba6457aa3fb4d.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-09T11:54:39.186Z", "updatedon": "2024-07-09T11:54:39.186Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/gliclaglaze-80-/1922", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLICLAGLAZE 80 ", "category": "DIABETIC RANGE", "tags": [ "Gliclazide 80mg side effects", "Gliclazide 80mg dosage", "Gliclazide 80mg Metformin 500mg", "Gliclazide 80mg price", "Gliclazide 80mg uses", "Gliclazide 80mg Uses in Hindi", "Gliclazide 80mg before or after meal" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6662c81c7247ae19c482b3d9", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "VILDIABATE 100 ", "description": "VILDIABATE 100 \nVildagliptin (100mg)\nIntroduction to VILDIABATE 100\nVILDIABATE 100 is an oral medication designed for the management of type 2 diabetes mellitus. It contains Vildagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor. Vildagliptin helps regulate blood sugar levels by enhancing the body’s natural ability to produce insulin and control glucose production. This medication is used in conjunction with diet and exercise to improve glycemic control in adults with type 2 diabetes.\n\nKey Component and Mechanism of Action\nVildagliptin 100mg\nVildagliptin is a potent and selective DPP-4 inhibitor. It works by inhibiting the DPP-4 enzyme, which is responsible for breaking down incretin hormones such as GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic peptide). These incretin hormones play a crucial role in glucose metabolism:\n\nGLP-1: Stimulates insulin secretion from the pancreatic beta cells in a glucose-dependent manner, inhibits glucagon release, slows gastric emptying, and reduces appetite.\nGIP: Enhances insulin secretion post-meal, aiding in the regulation of blood glucose levels.\nBy increasing the levels of these incretin hormones, Vildagliptin helps to improve insulin secretion in response to meals and reduces the amount of glucose produced by the liver.\n\nBenefits of VILDIABATE 100\nEffective Blood Sugar Control\nPostprandial Glucose Control: VILDIABATE 100 helps manage postprandial (after-meal) blood sugar levels by enhancing the body's natural response to food intake.\nFasting Glucose Control: By reducing hepatic glucose production, it also helps lower fasting blood sugar levels.\nAdditional Health Benefits\nLow Risk of Hypoglycemia: Vildagliptin has a low risk of causing hypoglycemia (low blood sugar) because it enhances insulin secretion only when blood glucose levels are elevated.\nWeight Neutral: Vildagliptin is generally weight neutral, making it a favorable option for patients concerned about weight gain associated with other diabetes medications.\nHow to Use VILDIABATE 100\nDosage and Administration\nRecommended Dosage: The typical dosage of VILDIABATE 100 is one tablet taken once or twice daily, depending on individual needs and the healthcare provider's instructions.\nAdministration: Take the tablet with or without food. Swallow it whole with a glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take VILDIABATE 100 regularly at the same time each day as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regular monitoring of blood sugar levels is important to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/vildiabate-100-133452", "price": 275.0, "discountamount": 82.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "GIP", "diet", "body", "EMAIL", "Order", "meals", "water", "glass", "GLP-1", "liver", "adults", "Action", "amount", "option", "potent", "readings", "Low Risk", "appetite", "exercise", "patients", "same time", "Mechanism", "regulation", "VILDIABATE", "one tablet", "Guidelines", "management", "food intake", "weight gain", "Optimal Use", "information", "conjunction", "Adjustments", "Introduction", "Vildagliptin", "sterisonline", "best results", "crucial role", "DPP-4 enzyme", "Hypoglycemia", "instructions", "sterispharma", "Key Component", "CALL/WHATSAPP", "typical dosage", "Consistent Use", "Administration", "treatment plan", "Weight Neutral", "natural ability", "oral medication", "low blood sugar", "glucagon release", "DPP-4) inhibitor", "natural response", "glycemic control", "individual needs", "gastric emptying", "insulin secretion", "incretin hormones", "glucose metabolism", "Recommended Dosage", "Regular monitoring", "healthcare provider", "blood glucose levels", "pancreatic beta cells", "dipeptidyl peptidase-4", "Fasting Glucose Control", "meal) blood sugar levels", "type 2 diabetes mellitus", "glucose-dependent manner", "selective DPP-4 inhibitor", "Additional Health Benefits", "hepatic glucose production", "other diabetes medications", "Postprandial Glucose Control", "Effective Blood Sugar Control", "glucose-dependent insulinotropic peptide" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1514, "imageuri": "https://productimages.withfloats.com/actual/667d3bc9c134db5b38ba8354.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d3bc9c134db5b38ba8354.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T08:43:08.09Z", "updatedon": "2024-06-27T10:15:31.785Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/vildiabate-100-/1514", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "VILDIABATE 100 ", "category": "DIABETIC RANGE", "tags": [ "vildagliptin 100 mg uses", "", "vildagliptin 100 mg generic medicine", "vildagliptin 100 mg side effects", "", "vildagliptin sustained release tablets 100 mg", "vildagliptin 100 mg brands in india" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6662acf3161afa2274ff5e9d", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "VILDIABATE 50 ", "description": "VILDIABATE 50 \nVildagliptin (50mg)\nIntroduction to VILDIABATE 50\nVILDIABATE 50 is an oral medication specifically designed for the management of type 2 diabetes mellitus. It contains Vildagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor. Vildagliptin works by enhancing the body's natural ability to regulate blood sugar levels, especially after meals. This medication is used in conjunction with diet and exercise to improve glycemic control in adults with type 2 diabetes.\n\nMechanism of Action\nVildagliptin\nVildagliptin is a potent and selective DPP-4 inhibitor. It works by inhibiting the DPP-4 enzyme, which degrades incretin hormones such as GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic peptide). These hormones play a crucial role in glucose metabolism:\n\nGLP-1: Stimulates insulin secretion from the pancreatic beta cells in a glucose-dependent manner, inhibits glucagon release, slows gastric emptying, and reduces appetite.\nGIP: Enhances insulin secretion post-meal, aiding in the regulation of blood glucose levels.\nBy increasing the levels of these incretin hormones, Vildagliptin helps to improve insulin release in response to meals and reduces the amount of glucose produced by the liver.\n\nBenefits of VILDIABATE 50\nEffective Blood Sugar Control\nPostprandial Glucose Control: VILDIABATE 50 helps manage postprandial (after-meal) blood sugar levels by enhancing the body's natural response to food intake.\nFasting Glucose Control: By reducing hepatic glucose production, it also helps lower fasting blood sugar levels.\nAdditional Health Benefits\nLow Risk of Hypoglycemia: Vildagliptin has a low risk of causing hypoglycemia (low blood sugar) because it enhances insulin secretion only when blood glucose levels are elevated.\nWeight Neutral: Vildagliptin is generally weight neutral, making it a favorable option for patients concerned about weight gain associated with other diabetes medications.\nHow to Use VILDIABATE 50\nDosage and Administration\nRecommended Dosage: The typical dosage of VILDIABATE 50 is one tablet taken once or twice daily, depending on individual needs and the healthcare provider's instructions.\nAdministration: Take the tablet with or without food. Swallow it whole with a glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take VILDIABATE 50 regularly at the same time each day as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regular monitoring of blood sugar levels is important to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/vildiabate-50-133451", "price": 249.0, "discountamount": 74.7, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "GIP", "body", "diet", "liver", "Order", "glass", "meals", "water", "EMAIL", "GLP-1", "option", "potent", "adults", "amount", "readings", "Low Risk", "appetite", "patients", "exercise", "Mechanism", "same time", "one tablet", "regulation", "VILDIABATE", "Guidelines", "management", "Adjustments", "weight gain", "information", "Optimal Use", "food intake", "conjunction", "Introduction", "sterisonline", "crucial role", "DPP-4 enzyme", "Hypoglycemia", "instructions", "sterispharma", "best results", "CALL/WHATSAPP", "treatment plan", "Consistent Use", "Weight Neutral", "typical dosage", "Administration", "natural ability", "oral medication", "low blood sugar", "insulin release", "glucagon release", "natural response", "DPP-4) inhibitor", "gastric emptying", "individual needs", "glycemic control", "incretin hormones", "insulin secretion", "Regular monitoring", "glucose metabolism", "Recommended Dosage", "Action Vildagliptin", "healthcare provider", "blood glucose levels", "pancreatic beta cells", "dipeptidyl peptidase-4", "Fasting Glucose Control", "meal) blood sugar levels", "type 2 diabetes mellitus", "glucose-dependent manner", "selective DPP-4 inhibitor", "other diabetes medications", "hepatic glucose production", "Additional Health Benefits", "Postprandial Glucose Control", "Effective Blood Sugar Control", "glucose-dependent insulinotropic peptide" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1494, "imageuri": "https://productimages.withfloats.com/actual/6662acf5364f23242470bc7d.png", "tileimageuri": "https://productimages.withfloats.com/tile/6662acf5364f23242470bc7d.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T06:47:15.345Z", "updatedon": "2024-06-28T11:41:29.762Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/vildiabate-50-/1494", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "VILDIABATE 50 ", "category": "DIABETIC RANGE", "tags": [ "VILDIABATE 50", "Vildagliptin (50mg)", "Vildagliptin 50mg side effects", "Vildagliptin tablets 50 mg uses", "Vildagliptin 50 mg price", "Vildagliptin 50 mg and metformin 500 mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6662aa04db100e1fdc2dcb68", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "VILDIABATE 100 ", "description": "VILDIABATE 100 \nVildagliptin (100mg)\nVILDIABATE 100 is a medication designed to manage type 2 diabetes mellitus by targeting specific aspects of glucose regulation. It contains Vildagliptin, an oral antidiabetic agent that belongs to the class of dipeptidyl peptidase-4 (DPP-4) inhibitors. Vildagliptin works by inhibiting the enzyme DPP-4, which is responsible for degrading incretin hormones like GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic peptide).\n\nHere are key points about VILDIABATE 100:\n\nMechanism of Action: Vildagliptin acts by inhibiting DPP-4, thereby increasing the levels of GLP-1 and GIP. These hormones play crucial roles in glucose metabolism:\n\nGLP-1 stimulates insulin secretion from pancreatic beta cells in a glucose-dependent manner. It also inhibits glucagon secretion, reduces appetite, and slows gastric emptying.\nGIP enhances insulin release in response to meals, contributing to postprandial glucose control.\nBlood Sugar Control: By enhancing insulin secretion and reducing glucagon levels, VILDIABATE 100 helps lower blood sugar levels, especially after meals. This mechanism targets both fasting and postprandial hyperglycemia, contributing to overall glycemic control.\n\nDosage and Administration: VILDIABATE 100 is typically taken orally once daily, preferably with a meal to maximize its effects on postprandial glucose levels. The dosage may vary depending on individual needs and response to treatment. It's essential to follow your healthcare provider's instructions regarding dosage and timing.\n\nEfficacy and Safety: Clinical studies have demonstrated the efficacy of Vildagliptin in lowering HbA1c levels (a marker of long-term glucose control) and improving glycemic parameters. It is generally well-tolerated, with common side effects including headache, nasopharyngitis (inflammation of the nose and throat), and upper respiratory tract infections. Serious side effects are rare but may include pancreatitis or hypersensitivity reactions.\n\nCombination Therapy: VILDIABATE 100 may be prescribed as monotherapy or in combination with other antidiabetic medications such as metformin or sulfonylureas. Combining medications with different mechanisms of action can provide synergistic benefits in managing diabetes.\n\nMonitoring and Follow-Up: Regular monitoring of blood sugar levels, kidney function, and other relevant parameters is important during treatment with VILDIABATE 100. Your healthcare provider may adjust the dosage or add/modify other medications based on your response and individual needs.\n\nLifestyle Modifications: In addition to medication, lifestyle modifications such as a healthy diet, regular exercise, weight management, and avoiding tobacco and excessive alcohol intake are essential components of diabetes management.\n\nIn conclusion, VILDIABATE 100 containing Vildagliptin is an effective oral antidiabetic medication that helps regulate blood sugar levels in patients with type 2 diabetes. It acts by enhancing insulin secretion and reducing postprandial glucose levels, contributing to improved glycemic control. However, it should be used under medical supervision, and adherence to prescribed dosage and lifestyle recommendations is crucial for optimal diabetes management.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/vildiabate-100-133452\n\n\n\n\n\n", "price": 275.0, "discountamount": 82.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "GIP", "nose", "GLP-1", "EMAIL", "class", "meals", "Order", "timing", "throat", "enzyme", "Safety", "Dosage", "marker", "tobacco", "fasting", "response", "addition", "appetite", "headache", "patients", "Efficacy", "metformin", "Follow-Up", "adherence", "treatment", "VILDIABATE", "conclusion", "key points", "information", "monotherapy", "healthy diet", "instructions", "sterisonline", "pancreatitis", "inflammation", "sterispharma", "HbA1c levels", "CALL/WHATSAPP", "sulfonylureas", "crucial roles", "Administration", "insulin release", "nasopharyngitis", "kidney function", "glucagon levels", "gastric emptying", "specific aspects", "Clinical studies", "individual needs", "regular exercise", "other medications", "Vildagliptin acts", "incretin hormones", "DPP-4) inhibitors", "weight management", "insulin secretion", "glucose metabolism", "glucose regulation", "glucagon secretion", "blood sugar levels", "Regular monitoring", "Combination Therapy", "glycemic parameters", "common side effects", "Blood Sugar Control", "medical supervision", "healthcare provider", "essential components", "synergistic benefits", "different mechanisms", "Serious side effects", "pancreatic beta cells", "dipeptidyl peptidase-4", "oral antidiabetic agent", "Lifestyle Modifications", "glucose-dependent manner", "excessive alcohol intake", "overall glycemic control", "type 2 diabetes mellitus", "lifestyle recommendations", "other relevant parameters", "long-term glucose control", "hypersensitivity reactions", "postprandial hyperglycemia", "optimal diabetes management", "postprandial glucose levels", "postprandial glucose control", "other antidiabetic medications", "upper respiratory tract infections", "effective oral antidiabetic medication", "glucose-dependent insulinotropic peptide" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1491, "imageuri": "https://productimages.withfloats.com/actual/6662aa0b364f23242470b3ca.png", "tileimageuri": "https://productimages.withfloats.com/tile/6662aa0b364f23242470b3ca.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T06:34:44.056Z", "updatedon": "2024-06-28T11:58:50.164Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/vildiabate-100-/1491", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "VILDIABATE 100 ", "category": "DIABETIC RANGE", "tags": [ "VILDIABATE 100", "Vildagliptin (100mg)", "Vildagliptin 100 mg uses", "Vildagliptin 100 mg price", "Vildagliptin 100 mg SR brand Name", "Vildagliptin 100 mg brands in India", "", "Vildagliptin 100 mg generic medicine", "Vildagliptin 100 mg side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6661ac5887f0960e14a2c914", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TENELIGOLD M 500 ", "description": "TENELIGOLD M 500 \nMetformin SR (500mg), Teneligliptin (20mg)\nTENELIGOLD M 500 is a combination medication containing Metformin Hydrochloride Sustained Release (SR) 500mg and Teneligliptin 20mg. It is primarily prescribed for the management of type 2 diabetes mellitus, a condition characterized by high blood sugar levels due to insulin resistance or inadequate insulin production.\n\nMetformin SR 500mg is a widely used oral antidiabetic medication that belongs to the biguanide class. It works by reducing the amount of glucose produced by the liver, increasing insulin sensitivity in muscle cells, and improving glucose uptake by tissues. This helps lower blood sugar levels and improves glycemic control.\n\nTeneligliptin 20mg is a dipeptidyl peptidase-4 (DPP-4) inhibitor. It enhances insulin secretion from pancreatic beta cells and inhibits glucagon secretion, leading to reduced blood glucose levels after meals. By targeting different pathways in glucose metabolism, Teneligliptin complements the action of Metformin, resulting in better overall glycemic control.\n\nBenefits of TENELIGOLD M 500:\nComprehensive Glycemic Control: The combination of Metformin and Teneligliptin addresses both fasting and postprandial (after-meal) blood sugar levels, providing comprehensive glycemic control throughout the day.\n\nImproved Insulin Sensitivity: Metformin improves insulin sensitivity in cells, allowing better utilization of glucose and reducing insulin resistance.\n\nEnhanced Incretin Effect: Teneligliptin enhances the incretin effect, which regulates insulin secretion and glucagon levels, leading to better glucose regulation.\n\nWeight Management: Metformin is associated with weight neutrality or modest weight loss, making it beneficial for overweight or obese individuals with diabetes.\n\nLow Risk of Hypoglycemia: The risk of hypoglycemia (low blood sugar) with TENELIGOLD M 500 is low when used appropriately, making it a safer option for many patients.\n\nHow to Use TENELIGOLD M 500:\nDosage: The typical dosage is one tablet taken orally once or twice daily, as directed by your healthcare provider. Dosage adjustments may be made based on blood sugar levels and individual response.\n\nAdministration: Take the tablet with meals to reduce gastrointestinal side effects and enhance absorption. Swallow it whole with a glass of water, and do not crush or chew the tablet unless advised otherwise.\n\nSafety Considerations:\nMedical History: Inform your doctor about any medical conditions you have, especially kidney or liver problems, as well as any medications or supplements you are taking.\n\nPregnancy and Nursing: Discuss the risks and benefits of TENELIGOLD M 500 if you are pregnant, planning pregnancy, or breastfeeding.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/teneligold-m-500-133449", "price": 122.75, "discountamount": 36.83, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "Order", "meals", "glass", "risks", "water", "EMAIL", "action", "option", "amount", "kidney", "doctor", "fasting", "reduced", "tissues", "Nursing", "Low Risk", "Benefits", "Pregnancy", "absorption", "overweight", "one tablet", "medications", "supplements", "utilization", "information", "TENELIGOLD M", "Hypoglycemia", "muscle cells", "sterispharma", "postprandial", "sterisonline", "many patients", "breastfeeding", "CALL/WHATSAPP", "typical dosage", "Administration", "liver problems", "glucose uptake", "low blood sugar", "Medical History", "glucagon levels", "biguanide class", "DPP-4) inhibitor", "Weight Management", "weight neutrality", "obese individuals", "insulin secretion", "glucose regulation", "modest weight loss", "Metformin SR 500mg", "glucose metabolism", "insulin resistance", "glucagon secretion", "different pathways", "Teneligliptin 20mg", "Dosage adjustments", "medical conditions", "insulin sensitivity", "healthcare provider", "individual response", "blood glucose levels", "Safety Considerations", "pancreatic beta cells", "combination medication", "dipeptidyl peptidase-4", "high blood sugar levels", "overall glycemic control", "Enhanced Incretin Effect", "meal) blood sugar levels", "type 2 diabetes mellitus", "oral antidiabetic medication", "gastrointestinal side effects", "inadequate insulin production", "Comprehensive Glycemic Control", "Metformin Hydrochloride Sustained Release" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1479, "imageuri": "https://productimages.withfloats.com/actual/6661ac5c4b296a211c2d34ee.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/6661ac5c4b296a211c2d34ee.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T12:32:24.912Z", "updatedon": "2024-06-29T05:26:50.914Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/teneligold-m-500-/1479", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TENELIGOLD M 500 ", "category": "DIABETIC RANGE", "tags": [ "TENELIGOLD M 500", "Metformin SR (500mg)", "Teneligliptin (20mg)", "Teneligliptin Tablets 20 mg uses", "Teneligliptin 20 mg price", "Teneligliptin 20 mg side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6661a4c8870e7b20c49e5b6e", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TENELIGOLD 20 ", "description": "TENELIGOLD 20 \nTeneligliptin (20mg)\nIntroduction to TENELIGOLD 20\nTENELIGOLD 20 contains Teneligliptin 20mg, a medication primarily used for the management of type 2 diabetes mellitus. Teneligliptin belongs to a class of drugs known as dipeptidyl peptidase-4 (DPP-4) inhibitors, which help control blood sugar levels by enhancing the body's own ability to regulate insulin after meals. This medication is typically used in combination with diet and exercise to improve glycemic control in adults with type 2 diabetes.\n\nWhat is Teneligliptin?\nOverview of Teneligliptin\nTeneligliptin is an oral diabetes medication that helps increase insulin production and decrease glucose production in the liver. It works by inhibiting the DPP-4 enzyme, which results in prolonged activity of incretin hormones. These hormones play a significant role in regulating glucose metabolism.\n\nMechanism of Action\nIncretin Hormones: Teneligliptin enhances the levels of incretin hormones, which increase insulin synthesis and release from pancreatic beta cells in response to meals.\nGlucose Regulation: It reduces the liver’s production of glucose, especially after meals, thereby helping to lower blood sugar levels.\nReduced Blood Sugar Spikes: By increasing insulin release and decreasing glucagon levels, Teneligliptin helps control blood sugar spikes after meals.\nBenefits of TENELIGOLD 20\nEffective Blood Sugar Management\nPostprandial Glucose Control: TENELIGOLD 20 helps manage postprandial (after-meal) blood sugar levels by enhancing the body’s natural response to meals.\nFasting Blood Sugar Control: It also helps in lowering fasting blood sugar levels, providing a balanced glycemic control throughout the day.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: TENELIGOLD 20 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nCombination Therapy: It can be used alone or in combination with other antidiabetic medications such as metformin, sulfonylureas, or insulin for enhanced glycemic control.\nAdditional Health Benefits\nWeight Neutral: Teneligliptin is generally weight neutral, making it a favorable option for patients concerned about weight gain associated with other diabetes medications.\nLow Risk of Hypoglycemia: When used alone, Teneligliptin has a low risk of causing hypoglycemia compared to some other diabetes medications.\nHow to Use TENELIGOLD 20\nDosage and Administration\nRecommended Dosage: The typical dosage of TENELIGOLD 20 is one tablet taken once daily. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with or without food. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take TENELIGOLD 20 regularly at the same time each day as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/teneligold-20-133447", "price": 165.0, "discountamount": 49.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "diet", "food", "body", "water", "drugs", "class", "EMAIL", "meals", "Order", "liver", "adults", "Action", "option", "ability", "Support", "Overview", "Low Risk", "readings", "patients", "metformin", "Mechanism", "same time", "TENELIGOLD", "full glass", "one tablet", "Guidelines", "information", "weight gain", "Optimal Use", "Adjustments", "Hypoglycemia", "sterispharma", "Introduction", "sterisonline", "best results", "DPP-4 enzyme", "sulfonylureas", "CALL/WHATSAPP", "Administration", "treatment plan", "typical dosage", "Consistent Use", "Weight Neutral", "glucagon levels", "insulin release", "natural response", "Exercise Adjunct", "significant role", "excellent adjunct", "insulin synthesis", "incretin hormones", "Recommended Dosage", "insulin production", "glucose production", "Glucose Regulation", "glucose metabolism", "prolonged activity", "Teneligliptin 20mg", "Combination Therapy", "individual response", "healthcare provider", "Diabetes Management", "Blood Sugar Control", "pancreatic beta cells", "lifestyle modifications", "meal) blood sugar levels", "type 2 diabetes mellitus", "oral diabetes medication", "enhanced glycemic control", "balanced glycemic control", "Additional Health Benefits", "Reduced Blood Sugar Spikes", "other diabetes medications", "Postprandial Glucose Control", "other antidiabetic medications", "Effective Blood Sugar Management", "dipeptidyl peptidase-4 (DPP-4) inhibitors" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1471, "imageuri": "https://productimages.withfloats.com/actual/6661a4ca0c19ea48b9490a9f.png", "tileimageuri": "https://productimages.withfloats.com/tile/6661a4ca0c19ea48b9490a9f.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T12:00:08.3Z", "updatedon": "2024-06-29T05:31:45.493Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/teneligold-20-/1471", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TENELIGOLD 20 ", "category": "DIABETIC RANGE", "tags": [ "TENELIGOLD 20", "Teneligliptin (20mg)", "Teneligliptin Tablets 20 mg uses", "Teneligliptin 20 mg price", "Teneligliptin 20 mg side effects", "Teneligliptin 20 mg uses in Hindi", "Teneligliptin+Metformin" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }

Still searching for
pancreatic beta cells?

Still searching for
pancreatic beta cells?

Chat with us